The Effect of Cholesterol Content on the Adjuvant Activity of Nucleic-Acid-Free Lipid Nanoparticles.

Authors:
Anindita J; Tanaka H; Yamakawa T; Sato Y; Matsumoto C and 12 more

Journal:
Pharmaceutics

Publication Year: 2024

DOI:
10.3390/pharmaceutics16020181

PMCID:
PMC10893020

PMID:
38399242

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Pharmaceutics

Abbreviation: Pharmaceutics

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
3D-Printed Alginate/Pectin-Based Patches Loaded with Olive Leaf Extracts for Wound Healing Applicat…
Patitucci F; Motta MF; Dattilo M and 8 more (2024) - Transparency Score: 3/6
3D Printing of Biodegradable Polymeric Microneedles for Transdermal Drug Delivery Applications.
Aldawood FK; Parupelli SK; Andar A and 1 more (2024) - Transparency Score: 3/6
4-(Phenylselanyl)-2H-chromen-2-one-Loaded Nanocapsule Suspension-A Promising Breakthrough in Pain M…
da Fonseca CAR; Prado VC; Paltian JJ and 10 more (2024) - Transparency Score: 4/6
A Bilayer Microarray Patch (MAP) for HIV Pre-Exposure Prophylaxis: The Role of MAP Designs and Form…
Vora LK; Tekko IA; Zanutto FV and 7 more (2024) - Transparency Score: 3/6
Acylation of Oleanolic Acid Oximes Effectively Improves Cytotoxic Activity in In Vitro Studies.
Bednarczyk-Cwynar B; Ruszkowski P. (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest Taiji Oyama and Satoko Suzuki are employees of JASCO Corporation. The other authors have no conflicts of interest to disclose. The founders had no role in either the research administration or in the writing of the manuscript."

Evidence found in paper:

"H. Tanaka was supported by the JSPS KAKENHI (21K18035). H. Akita was supported by a JST CREST grant (grant number JPMJCR17H1), JSPS KAKENHI (grant numbers 20H00657 and 21K18320), the Basic Science and Platform Technology Program for Innovative Biological Medicine from the Japan Agency for Medical Research and Development (AMED) under grant number JP21gm1610006, and the Canon Foundation Research Grant Program."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025